These HFn NPs naturally target the transferrin receptor 1 (TfR1), which is highly expressed on both the BBB and many tumor cells, enabling H-TZ to cross the BBB and specifically bind to HER2+ tumor cells [76]. Here, TFRC is linked to neoplasm.